Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC

NVCTNVCT
2 quarters

Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in NUVECTIS PHARMA INC

Yes. Vanguard Portfolio Management holds 118,297 shares of NVCT (Nuvectis Pharma), worth $2.2M, as of its Q2 2026 13F filing. It increased the position by 26,143 shares (+28.4%) from Q1 2026. Vanguard Portfolio Management has held NVCT in every 13F on record since Q1 2026, 2 quarterly filings.

Current Value

$2.2M

Current Shares

118,297

Total Value Change

+$1.5M

Total Shares Change

+26,143

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
118,297
+28.4%
$2.2M0.0%$18.39
32
2026-Q1
First report
92,154
-
$712,3500.0%$7.73
0

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used